Xinglin Wu
St. Michael's Hospital(CA)University of Toronto(CA)Children's Hospital of Chongqing Medical University(CN)Fuzhou University(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Bone Tissue Engineering Materials, Cardiac Arrhythmias and Treatments, Osteoarthritis Treatment and Mechanisms
Most-Cited Works
- → Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3(2008)623 cited
- → Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities(2001)121 cited
- → Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics(2003)115 cited
- → High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma(1997)71 cited
- → Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species(2009)63 cited